13F

Stock

Chemomab Therapeutics Ltd.

CMMB · held by 14 managers

Reported value

$588.2K

Holders

14

+0 new · −0 exited

Holders’ est. mark

−$3.7K

Price effect on 1 books still in the name

Largest holder

$171.2K

Citadel

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Citadel103.8K$171.2KHeld
ADAR1 Capital Management, LLC80K$132KHeld
Ikarian Capital, LLC51.8K$85.5KHeld
KESTRA PRIVATE WEALTH SERVICES, LLC51.7K$85.3KHeld
XTX Topco Ltd19K$31.4KHeld
RHUMBLINE ADVISERS17.9K$29.5KHeld
JANE STREET GROUP, LLC15.6K$25.7KHeld
BNP PARIBAS FINANCIAL MARKETS8.13K$13.4KHeld
MORGAN STANLEY3.77K$6.23K−$3.7KCut−$230.6K
GAMMA Investing LLC2.51K$4.15KHeld
UBS Group AG2.25K$3.72KHeld
SBI Securities Co., Ltd.26$43Held
Virtu Financial LLC10.9K$18Held
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO2$3Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.